Corriente Advisors

Omnitron Sensors is a developer of advanced sensor technology aimed at enhancing the safety and autonomy of self-driving cars and drones. The company specializes in silicon photonics processes to create high-performance and cost-effective sensors that are essential for safety-critical applications. By providing tools that facilitate full autonomy, Omnitron Sensors enables clients to implement reliable solutions for driverless vehicles, ensuring safe navigation in various environments.

Omnitron Sensors is a developer of advanced sensor technology aimed at enhancing the safety and autonomy of self-driving cars and drones. The company specializes in silicon photonics processes to create high-performance and cost-effective sensors that are essential for safety-critical applications. By providing tools that facilitate full autonomy, Omnitron Sensors enables clients to implement reliable solutions for driverless vehicles, ensuring safe navigation in various environments.

Neurologix, Inc. is a clinical-stage biotechnology company focused on the discovery and development of gene therapy treatments for serious disorders of the brain and central nervous system. The company aims to provide alternatives to traditional surgical and pharmacological interventions. Its primary areas of research include therapies for Parkinson's disease and epilepsy, conditions that significantly impact patients' quality of life. Additionally, Neurologix is involved in developing gene transfer therapies for other neurodegenerative and metabolic disorders, such as Huntington's disease, depression, and genetically-based obesity. Founded in 1999, Neurologix is headquartered in Fort Lee, New Jersey.